NKTR logo

Nektar Therapeutics

NKTR

$0.76

+ $0.23 (42.08%) This month

Closed: 1 Mar 2024 21:00 US/Eastern

Key details

CEO

Howard Robin

Employees

820

Headquarters

San Francisco, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Nektar Therapeutics

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG